Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.43 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | DUT | P33316 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.35 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.35 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.35 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.35 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.34 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.34 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.34 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2787886 | 1.00 | CRBN (0.43) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL28488142 | 0.80 | CRBN (0.42) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL30087060 | 0.80 | CRBN (0.46) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL5290093 | 0.80 | CRBN (0.46) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL22559553 | 0.80 | CRBN (0.42) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL6666895 | 0.77 | POLB (0.47) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL24211424 | 0.77 | CRBN (0.50) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL2983403 | 0.77 | CRBN (0.50) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL23950038 | 0.77 | CRBN (0.45) | CRBNDDB1POLBHSD17B10DUT | |
| SCHEMBL23171170 | 0.74 | POLB (0.44) | CRBNDDB1POLBHSD17B10DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1308511-A1 | Use of angiopoietin-like 1 and angiopoietin-like 2 nucleic acids and proteins for the treatment of blood-related disorders and defects in vasculature. | Mermaid Pharmaceuticals GmbH (DE) | 2003-05-07 | — | — | EP | claimed |
| EP-4735029-A2 | MULTIVALENT INFLUENZA MRNA VACCINES | Sanofi Vaccines US Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20250340937-A1 | COLORECTAL CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS | CHRONIX BIOMEDICAL (US) | 2025-11-06 | — | — | US | disclosed |
| EP-4622630-A1 | COMPOSITIONS OF DRY POWDER FORMULATIONS OF MESSENGER RNA AND METHODS OF USE THEREOF | Translate Bio, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| US-12359252-B2 | Colorectal cancer associated circulating nucleic acid biomarkers | CHRONIX BIOMEDICAL (US) | 2025-07-15 | — | — | US | disclosed |
| US-20250171764-A1 | PURIFICATION OF NUCLEIC ACIDS USING COPPER-TITANIUM OXIDES | ABBOTT MOLECULAR INC. | 2025-05-29 | — | — | US | disclosed |
| EP-4555102-A1 | SCALABLE, SUBMICRON-RESOLUTION REPLICATION OF DNA ARRAYS | Topogene Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025003756-A2 | MULTIVALENT INFLUENZA MRNA VACCINES | SANOFI (FR) | 2025-01-02 | — | — | WO | disclosed |
| US-20240401120-A1 | METHODS FOR BIAS-FREE QUANTIFICATION OF RNA | CHRONIX BIOMEDICAL (US) | 2024-12-05 | — | — | US | disclosed |
| EP-4409031-A1 | METHODS FOR BIAS-FREE QUANTIFICATION OF RNA | Chronix Biomedical (US) | 2024-08-07 | — | — | EP | disclosed |
| EP-0789707-A4 | AMINO ACID NUCLEIC ACIDS | ICN PHARMACEUTICALS (US) | 1999-02-24 | — | — | EP | disclosed |
| WO-1998039431-A1 | SR-BI REGULATORY SEQUENCES AND THERAPEUTIC METHODS OF USE | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1998-09-11 | — | — | WO | disclosed |
| WO-1998036065-A1 | DIFFERENTIATION ENHANCING FACTORS AND USES THEREFOR | DANA-FARBER CANCER INSTITUTE (US) | 1998-08-20 | — | — | WO | disclosed |
| WO-1998017688-A1 | OSTEOMETRIN RELATED PEPTIDES AND NUCLEIC ACIDS AND DIAGNOSIS AND THERAPIES USING THEM | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1998-04-30 | — | — | WO | disclosed |
| EP-0789707-A1 | AMINO ACID NUCLEIC ACIDS | ICN PHARMACEUTICALS (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1996014330-A1 | AMINO ACID NUCLEIC ACIDS | ICNPHARMACEUTICALS (US) | 1996-05-17 | — | — | WO | disclosed |
| WO-1995011911-A1 | BINDING COMPETENT OLIGOMERS CONTAINING UNSATURATED 3',5' AND 2',5' LINKAGES | GLAXO WELLCOME INC. (US) | 1995-05-04 | — | — | WO | disclosed |
| EP-0616612-A4 | NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE. | GILEAD SCIENCES INC (US) | 1995-01-11 | — | — | EP | disclosed |
| EP-0616612-A1 | NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE | GILEAD SCIENCES, INC. (US) | 1994-09-28 | — | — | EP | disclosed |
| WO-1993012135-A1 | NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE | GILEAD SCIENCES, INC. (US) | 1993-06-24 | — | — | WO | disclosed |